Z-Pack: Cardiovascular Risks??

The FDA announced today that it is looking into a recent study in the New England Journal of Medicine that reported an increase in cardiovascular deaths, and in the risk of death from any cause, in persons treated with a 5-day course of azithromycin (Zithromax) compared to persons treated with other antibiotics.
I’ve used the Z-Pack numerous times in my life and I always thought it was safe. But, as a drug lawyer, I should know better. The pharmaceutical companies never, and I do mean never, adequately test their drugs before they are released to the general public. In essence, we are all guinea pigs for the drug companies as they “test” their drugs using post-market surveillance data. In other words, they sell you a product and then sit back and see how many people it hurts before they decide to make a label change to warn of the true risks associated with their products.
But, even worse, they try every trick in the book to hide the true risks of their drugs from the general public. And what happens when the hammer finally falls and they start getting sued? They fight like hell, and then pay a couple billion to make the problem go away, and pocket several more billion in profits in the process. I guess it is a cost of doing business to them, but I see the true agony that they cause every day as I represent my clients. I must say, I find this conduct disgusting.
What are your thought? Share them with attorney Larry Jones at www.the-recall-lawyers.com
or by email to larry@jonesward.com